We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual ... Xenetic Biosciences Inc is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a pipeline of therapeutic assets targeting oncology indications. It also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin resistant endometrial cancer. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.15 | 4 | 3.75 | 4.34 | 3.75 | 2497 | 4.11298985 | CS |
4 | -0.58 | -12.9464285714 | 4.48 | 4.74 | 3.74 | 3443 | 4.19035687 | CS |
12 | 0.26 | 7.14285714286 | 3.64 | 4.74 | 3.3301 | 5556 | 4.18376828 | CS |
26 | 0.45 | 13.0434782609 | 3.45 | 4.74 | 2.8696 | 5269 | 3.86952198 | CS |
52 | -0.6 | -13.3333333333 | 4.5 | 5.97 | 2.55 | 14012 | 3.70216954 | CS |
156 | -15.7 | -80.1020408163 | 19.6 | 56.8 | 2.40101 | 942752 | 29.43478143 | CS |
260 | -9.9 | -71.7391304348 | 13.8 | 152.5 | 2.40101 | 888942 | 27.29584059 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions